IDH1 for Ivosidenib (Tibsovo)

Alphabetical Test listing

IDH1 for Ivosidenib (Tibsovo)-994

November 30, 2021

Due to reagent procurement issues and/or staffing shortages at Versiti, the turn-around-time for this assay may be extended.

IDH1 for Ivosidenib (Tibsovo)
IDH Isocitrate dehydrogenase 1

An aid in identifying acute myeloid leukemia (AML) patients with an isocitrate dehydrogenase-1 (IDH1) mutation for treatment with TIBOSVO® (ivosidenib).

EDTA whole blood
5.0 mL
1.0 mL

Do not spin; submit entire specimen


Lavender (EDTA), 4mL

EDTA bone marrow

Lavender (EDTA), 4mL

  • Indicate on specimen tube and requisition whether sample is from whole blood or bone marrow.
  • Versiti requisition form
  • Molecular Medicare billing request
    • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
    • All information requested is required in order for your request to be completed


Versiti Blood Center of WI (7647): R-NX
5 - 7 days

Abbott Realtime IDH1

This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.